Brief: Therapeuticsmd Announces Full Year 2022 Financial Results And Provides Update On Business Model Transition
April 7 (Reuters) - TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD ANNOUNCES FULL YEAR 2022 FINANCIAL RESULTS
AND
PROVIDES UPDATE ON BUSINESS MODEL TRANSITION
* THERAPEUTICSMD INC- AS OF DECEMBER 31, 2022, COMPANY'S
CASH ON
HAND TOTALED $38.1 MILLION COMPARED WITH $64.9 MILLION AS OF
DECEMBER 31, 2021
Source text for Eikon: ID:nBw3vWLh3a
Further company coverage: TXMD.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract